Analytics

Equity Analytics

On the record this week: what the Street published, what insiders filed, and what reports next.

Equity Analytics/IPN.PA

IPN.PA

Ipsen S.A.

Healthcare - FR

Ipsen S.A. is a global biopharmaceutical company specializing in the research, development, manufacture, and commercialization of innovative medicines primarily in the fields of oncology, neuroscience, and rare diseases. The company's core…

HQ: Paris, IF, Francewww.ipsen.com

EUR156.40-1.32%vs prev. close

Market snapshot

Price

EUR156.40

Daily move

-1.32%

P/E

25.4

EPS TTM

6.18

Dividend yield

1.02%

Beta

0.32

Market cap

15.1B

Price history

IPN.PA price

EUR

VolumeLog scale

No price history available

Next earnings

No upcoming earnings report scheduled in the next 6 months.

Peer comparison

Company	Ticker	Industry	Mkt cap (USD bn)	P/E	Div yld	1W	1M	3M	6M	1Y	YTD
Ipsen	IPN.PA	Drug Manufacturers - Specialty & Generic	15.1	25.4	1.02%	-7.2%	+0.6%	-0.5%	+2.0%	+32.8%	+31.4%

Subscribe to Equity Analytics to compare IPN.PA with its closest peers

Sector-matched peer set with side-by-side valuation, dividend and performance over every window.

View plans

Ask Ashenden

One question, one concise answer grounded in Ashenden research.

Built on Ashenden research and our own data. Answers are AI-generated: they can be wrong or incomplete — check anything you would act on.